ViewRay (NSDQ:VRAY) said today it won Japanese Ministry of Health, Labor and Welfare Shonin approval for its MRIdian Linac linear accelerator system. The newly cleared MRIdian Linac device replaces the cobalt it utilized with linear accelerator technology, the Cleveland, Ohio-based company said. The company won FDA approval for the device last February. ViewRay touted the MRIdian as the […]
ViewRay Inc.
ViewRay adds another $59m from Chinese backer Fosun
ViewRay (NSDQ:VRAY) said it added another $59.1 million it its coffers in an equity and warrants sale to Chinese investment firm Fosun International, following a $50 million offering last year. Fosun, which took out a 9.9% stake in ViewRay last October in a $50 million round, is slated to own 18.4% of the Cleveland-area linear accelerator […]
ViewRay raises $50m
ViewRay (NSDQ:VRAY) said today it raised $50 million in a new direct offering to support ongoing commercialization of its MRIdian linear accelerator technology and further research & development. In the offering, the Cleveland, Ohio-based company floated approximately 8.4 million shares of its common stock at $5.95 per share, while affiliates of the company paid $6.44 per share. […]
ViewRay wins 510(k) for MRIdian Linac system, touts Q4, FY2016 prelim results
ViewRay (NSDQ:VRAY) today announced it won FDA 510(k) clearance for its MRIdian Linac system, and released its preliminary earnings for the 4th quarter and full fiscal year 2016. The newly cleared MRIdian Linac device replaces the cobalt it utilized with linear accelerator technology, the Cleveland, Ohio-based company said. “FDA clearance of the MRIdian Linac is a transformative milestone […]
ViewRay brings in $26m from private placement
ViewRay (NSDQ:VRAY) said today it raised $26.1 million in a private placement of common stock and warrants to support the ongoing commercialization of its MRIdian linear accelerator tech. In the placement, Cleveland-based ViewRay said it sold approximately 8.6 million shares of common stocks with warrants to purchase an additional 1.7 million shares, with an exercise prise […]
ViewRay wins CE mark for MRIdian Linac scanner
ViewRay (NSDQ:VRAY) said today it won CE Mark approval in the European Union for its MRIdian Linac next-gen linear accelerator-based MRI-guided radiation therapy system. The newly cleared MRIdian Linac device replaces the cobalt it utilized with linear accelerator technology, Cleveland-based ViewRay said. “We are excited to have CE Mark approval and to begin selling MRIdian Linac within Europe. […]
China OKs ViewRay’s MRIdian radiation therapy device
ViewRay (NSDQ:VRAY) said today it won clearance from the China Food and Drug Administration for its MRIdian MRI-guided radiation therapy system. The MRIdian system is designed to integrate full-time MR imaging, cobalt radiation delivery and software automation for cancer treatment throughout the body, the Cleveland, Ohio-based company said. “China is one of the largest markets for medical […]
ViewRay raises $14m in private placement
ViewRay (NSDQ:VRAY) said today that it raised nearly $14 million in a private placement as it gears up to launch its MRIdian linear accelerator, saying it expects to win regulatory nods in the U.S. and overseas by the end of the year. Cleveland-based ViewRay said the round was led by existing backers OrbiMed Advisors, Xeraya Capital and Kearny Venture […]
NuVasive co-founder McKinley is Vascular Dynamics new COO | Personnel Moves June 9, 2016
NuVasive co-founder McKinley is Vascular Dynamics new COO Vascular Dynamics said it tapped NuVasive Inc. (NSDQ:NUVA) co-founder and former CEO James McKinley as its new chief operating officer. McKinley has held leadership positions at Advent Medical, Endosphere, Farallon Medical and Nellix, as well as NuVasive. “It is a tremendous opportunity to add Jim to our management team. […]
Ex-Insulet CEO DeSisto is new chief exec at MannKind | Personnel Moves
MannKind Corporation said last week it picked up ex-Insulet (NSDQ:PODD) CEO Duane DeSisto as its new prez and CEO, effective January 5, 2016. DeSisto will replace interim CEO Alfred Mann, who has held the spot since November. DeSisto will also join the company’s board of directors, according to a press release from the Valencia, Calif.-based company. […]
ViewRay closes $27m private placement
ViewRay said today it closed a $26.7 million private placement round, floating 5.3 million shares of common stock to support its MRIdian MRI-guided radiation therapy device. The round included investors Aisling Capital, Fidelity, Kearny Venture Partners, Montrose Capital, OrbiMed and Xeraya Capital. Funds from the round will support commercialization of the MRIdian device, research and […]